Parmax Pharma Limited (PARMAX) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE240T01014
₹132.45+1.30 (+0.99%)
Key metrics
- Market Cap
- ₹50 Cr
- P/E Ratio
- —
- EPS
- -3.21
- Book Value
- -16.43
- P/B Ratio
- —
- ROE
- 67.65%
- ROCE
- -86.63%
- Debt / Equity
- -1.87
- Net Margin
- -34.34%
- Revenue Growth
- -57.06%
- Profit Growth
- -98.62%
- Dividend Yield
- —
- 52W High
- ₹132.45
- 52W Low
- ₹22.60
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Parmax Pharma Limited
Parmax Pharma Limited operates in the pharmaceutical business in India. It manufactures and sells bulk drugs, drug intermediates, and specialty chemicals. The company was incorporated in 1994 and is based in Rajkot, India.
- Headquarters
- Rajkot, India
- Promoter Holding
- 30.84%
The full Parmax Pharma Limited analysis
Create a free account to open the complete PARMAX deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.